Kenneth Koury Selected Research

Kenneth Koury Research Topics

12	COVID-19 03/2024 - 10/2020
7	Infections 01/2022 - 08/2009
4	Chronic Hepatitis C 09/2010 - 08/2009
3	Pain (Aches) 01/2021 - 11/2017
2	Headache (Headaches) 01/2021 - 12/2020
2	Fatigue 01/2021 - 12/2020
2	Hepatitis C 08/2010 - 08/2009
1	Myocarditis (Carditis) 03/2024
1	Pericarditis 03/2024
1	Human Influenza (Influenza) 09/2023
1	Fever (Fevers) 01/2023
1	Neoplasms (Cancer) 01/2022
1	Patella Fracture 04/2021
1	Knee Injuries (Knee Injury) 11/2017
1	Femoral Fractures (Femoral Fracture) 11/2017
1	Rare Diseases (Rare Disease) 01/2017
1	Anemia 11/2010
1	Hemolysis 11/2010
1	Dysgeusia (Parageusia) 08/2010
1	Virus Diseases (Viral Diseases) 08/2010
1	Body Weight (Weight, Body) 08/2009

12	BNT162 VaccineIBA 03/2024 - 10/2020
10	VaccinesIBA 09/2023 - 01/2017
4	mRNA VaccinesIBA 03/2024 - 10/2020
4	Ribavirin (Virazole)FDA LinkGeneric 11/2010 - 08/2009
2	Messenger RNA (mRNA)IBA 03/2024 - 01/2022
2	peginterferon alfa-2b (Pegintron)FDA Link 08/2010 - 08/2009
1	Immunoglobulin G (IgG)IBA 09/2023
1	COVID-19 VaccinesIBA 01/2022
1	Stainless Steel (Steel, Stainless)IBA 04/2021
1	HematinicsIBA 11/2010
1	oxidized low density lipoproteinIBA 09/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2010
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2010
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2010
1	Antiviral Agents (Antivirals)IBA 08/2010
1	InterleukinsIBA 07/2010
1	Interferon-alpha (Interferon Alfa)IBA 07/2010
1	peginterferon alfa-2a (Pegasys)FDA Link 08/2009

2	Therapeutics 09/2010 - 07/2010
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2020
1	Traction 11/2017
1	Drug Tapering 11/2010